Arista Networks Margin Miss Dampens Share Valueby Mark Eisenberg 13.02.2024Shares in Arista Networks plunge after missing margin expectations for the first quarter. Despite this setback, the company's strong sales ...
Roadzen Surges 372%: Taming Losses & Expanding Globallyby Terry Bingman 13.02.2024Roadzen Inc. reports impressive Q3 revenue growth of 372% but also discloses a net loss of $30.57 million. The company's ...
Chainlink Overtakes Dogecoin in Market Cap Shiftby John Darbie 13.02.2024Chainlink has overtaken Dogecoin to become the 11th most valuable cryptocurrency, with a market cap of $11.46 billion. Dogecoin's decline ...
Cadence’s Stock Drop on Soft Revenue Outlookby Terry Bingman 13.02.2024Cadence Design Systems reports strong Q4 results with record revenue, but stock drops on soft revenue guidance for next quarter.
Bezos vs Musk: Richest Title Showdownby Mark Eisenberg 13.02.2024Jeff Bezos aims to reclaim the title of the world's richest person from Elon Musk by selling up to 50 ...
Starbucks Valentine’s Drinks: Hit or Miss?by Lilu Anderson 12.02.2024Starbucks introduces two delicious Valentine's Day drinks - Chocolate Hazelnut Cookie Cold Brew and Chocolate-Covered Strawberry Crème Frappuccino. These limited-time ...
2024’s Investment Darling: Surprising Industry Revealedby Terry Bingman 12.02.2024Investment newsletters have revealed their top picks for 2024, but the favored industry remains a mystery. With competition increasing, the ...
Israeli Stocks Soar, Led by Teva’s 3-Year Highby Mark Eisenberg 12.02.2024Israel's stock market closed higher as several sectors led gains. Teva Pharmaceutical Industries Ltd and Azrieli Group Ltd performed well. ...
Bitcoin Boom: ETFs Ignite Frenzy, Experts Predict Surgeby John Darbie 12.02.2024Bitcoin's recent surge in price sparks investor interest, but caution prevails in the crypto market due to vulnerabilities and uncertainty ...
FDA Clears T2 Biosystems’ Key Update in Sepsis Battleby Lilu Anderson 12.02.2024T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...